関連する実験動画

Updated: Jan 7, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

血のp-tauとp-tau/Aβ比率とアルツハイマー病の病理学的関連

Xuhui Chen1, Mingxing Jiang2, Laihong Zhang3

  • 1Department of Neurology, Peking University First Hospital, Beijing 100034, China; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518132, China.

The journal of prevention of Alzheimer's disease
|January 1, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
アルツハイマー病脳の縮小認知機能の低下P-tau についてプラズマバイオマーカーβ-アミロイド

さらに関連する動画

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-145105:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

751
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.8K

関連する概念動画

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K